This inventor holds 2 USPTO granted patents. Top assignees: Institute of Organic Chemistry and Biochemistry, Rega Stichting, V.z.w.. Active years: 1994-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Horni Pocernice, CZ (1994)
- Praha, CZ (1998)
Company Filing History:
Years Active: 1994-1998
Title: Jindrich Jindrich: Innovator in Pharmaceutical Chemistry
Introduction
Jindrich Jindrich is a notable inventor based in Horni Pocernice, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of antiviral compounds. His work has led to the creation of innovative solutions aimed at combating viral infections.
Latest Patents
Jindrich holds 2 patents that focus on N-(3-fluoro-2-phosphonylmethoxypropyl) derivatives of purine and pyrimidine heterocyclic bases. These patents detail a method for producing these compounds and their application as active principles in drugs. The inventions specifically target the suppression of virus multiplication, especially retroviruses, through the use of these new compounds. The compounds are synthesized by reacting N-(3-fluoro-2-hydroxypropyl) derivatives of purine and pyrimidine heterocyclic bases with diesters of p-toluenesulfonyloxymethylphosphonic acid in the presence of sodium hydride.
Career Highlights
Throughout his career, Jindrich has worked at esteemed institutions such as the Institute of Organic Chemistry and Biochemistry of the Academy of Sciences and Rega Stichting. His research has significantly advanced the understanding and treatment of viral infections.
Collaborations
Jindrich has collaborated with notable colleagues, including Antonin Holy and Erik D De Clercq. These partnerships have enriched his research and contributed to the success of his inventions.
Conclusion
Jindrich Jindrich's innovative work in the field of pharmaceutical chemistry has led to the development of important antiviral compounds. His contributions continue to impact the medical community and offer hope in the fight against viral diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile